Abstract:Dip2C is highly expressed in brain and many other tissues but its biological functions are still not clear. Genes regulated by Dip2C in brain have never been studied. The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein (Cas) systems, adaptive immune systems of bacteria and archaea, have been recently developed and broadly used in genome editing. Here, we describe targeted gene deletions of Dip2c gene in mice via CRISPR/Cas9 system and study of brain transcriptome under Dip2C regulation. The CRISPR/Cas9 system effectively generated targeted deletions of Dip2c by pronuclei injection of plasmids that express Cas9 protein and two sgRNAs. We achieved targeted large fragment deletion with efficiencies at 14.3% (1/7), 66.7% (2/3) and 20% (1/5) respectively in 3 independent experiments, averaging 26.7%. The large deletion DNA segments are 160.4kb (Dip2CΔ160kb), spanning from end of exon 4 to mid of exon 38. A mouse with two base pair deletion was generated from a single sgRNA targeting in exon 4 (Dip2cΔ2bp) by non-homologous end joining (NHEJ). Loss of gene expression for Dip2c mRNA was confirmed by quantitative real time PCR (qPCR). Dip2C-regulated genes and pathways in brain were investigated through RNAseq of Dip2cΔ2bp. In total, 838 genes were found differentially regulated, with 252 up and 586 down. Gene ontology (GO) analysis indicated that DEGs in brain are enriched in neurological functions including 'memory', 'neuropeptide signaling pathway', and 'response to amphetamine' while KEGG analysis shows that 'neuroactive ligand-receptor interaction pathway' is the most significantly enriched. DEGs Grid2ip, Grin2a, Grin2c, Grm4, Gabbr2, Gabra5, Gabre, Gabrq, Gabra6 and Gabrr2 are among the highly regulated genes by Dip2C. Results confirm Dip2C may play important roles in brain development and function.

Knockout of Dip2c in Murine ES Cell Line IBMSe001-B-1 by CRISPR/Cas9 Genome Editing Technology

Generation of Dip2a Homozygous Knockout Murine ES Cell Line IBMSe001-A-1 Via CRISPR/Cas9 Technology

Generation of a Lamin A/C Knockout Human Induced Pluripotent Stem Cell Line (Zjulli007-A) Via CRISPR/Cas9

Brain transcriptome study through CRISPR/Cas9 mediated mouse Dip2c gene knock-out

Transcriptomic Profiling of Dip2a in the Neural Differentiation of Mouse Embryonic Stem Cells

Loss of Dip2b Leads to Abnormal Neural Differentiation from Mescs.

Generation of a Bag1 Homozygous Knockout Mouse Embryonic Stem Cell Line Using CRISPR/Cas9.

CRISPR-Cas9-mediated Genome Editing in One Blastomere of Two-Cell Embryos Reveals a Novel Tet3 Function in Regulating Neocortical Development

Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model

Generation of a TSC2 knockout embryonic stem cell line by CRISPR/Cas9 editing

Large genomic fragment deletion and functional gene cassette knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos

CRISPR/Cas9 Mediated Generation of a Ipsc Line EHTJUi005-A-1 with Homozygous Knockout of the SUV39H1 Gene.

Generation of a DAPK1 Knockout First (conditional Ready) Human Embryonic Stem Cell Line (Zssye001-A) by CRISPR-Cas9 Technology.

Generation of Mouse Haploid Somatic Cells by Small Molecules for Genome-wide Genetic Screening.

CRISPR–Cas9-mediated Base-Editing Screening in Mice Identifies DND1 Amino Acids That Are Critical for Primordial Germ Cell Development

Establishment of Heterozygous LMOD2 Knockout Human Embryonic Stem Cell Line (Zzuneui022-a-1) Using CRISPR/Cas9 System

Spermatogenic Cell-Specific Gene Mutation in Mice Via CRISPR-Cas9.

Generation of VDR Knock-Out Mice Via Zygote Injection of CRISPR/Cas9 System

Functional Dissection of Pri-Mir-290~295 in Dgcr8 Knockout Mouse Embryonic Stem Cells.

CRISPR-Cas9-Mediated Genetic Screening in Mice with Haploid Embryonic Stem Cells Carrying a Guide RNA Library

Gene Knockout in Highly Purified Mouse Hematopoietic Stem Cells by CRISPR/Cas9 Technology.